Skip to main content
    • Aa
    • Aa

An approach to the management of paroxysmal laryngospasm

  • R J Obholzer (a1), S A R Nouraei (a1), J Ahmed (a1), M R Kadhim (a1) and G S Sandhu (a1)...

To review the presentation, risk factors and management of paroxysmal laryngospasm.

Study design:

Retrospective review of cases.


A teaching hospital otolaryngology department with a subspecialty interest in airway disorders.


All patients diagnosed with laryngospasm over a two-year period were reviewed. Information was obtained about disease presentation, risk factors, management and symptom resolution.


Laryngospasm was diagnosed in nine women and six men. The average age at presentation was 56±6.5 years, and there was an 80 per cent association with gastroesophageal reflux disease. Proton pump inhibitors led to complete symptom resolution in six patients and to partial symptomatic relief, requiring no further treatment, in a further four patients. Of the remaining five patients unresponsive to proton pump inhibitor therapy, two continued to experience syncopal episodes due to laryngospasm. Both these patients achieved complete remission after laryngeal botulinum toxin injection. Symptoms recurred after three to four months and were successfully treated with a repeat injection.


The primary risk factor for spontaneous laryngospasm is laryngopharyngeal reflux. Symptoms are distressing and may be relieved in most cases by treatment aimed at suppressing gastric acid secretion. Laryngeal botulinum toxin injection appears to be a viable treatment modality in selected patients with refractory symptoms.

Corresponding author
Address for correspondence: Mr Rupert Obholzer, 5 Little Saint Leonards, London SW14 7LT, UK. Fax: +44 870 4580775 E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2 DR Maceri , S Zim . Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). Laryngoscope 2001;111:1976–9

3 R Thurnheer , S Henz , A Knoblauch . Sleep-related laryngospasm. Eur Respir J 1997;10:2084–6

4 PL Chodosh . Gastro-esophago-pharyngeal reflux. Laryngoscope 1977;87:1418–27

6 J Poelmans , J Tack , L Feensta . Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux? Dig Dis Sci 2004;49:1868–74

7 M Charlson , TP Szatrowski , J Peterson , J Gold . Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–51

9 J Poelmans , J Tack . Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 2005;54:1492–9

11 SD Schaefer . Neuropathology of spasmodic dysphonia. Laryngoscope 1983;93:1183–204

12 P Woo , M Mangaro . Aberrant recurrent laryngeal nerve reinnervation as a cause of stridor and laryngospasm. Ann Otol Rhinol Laryngol 2004;113:805–8

13 G Cantarella , A Berlusconi , B Maraschi , A Ghio , S Barbieri . Botulinum toxin injection and airflow stability in spasmodic dysphonia. Otolaryngol Head Neck Surg 2006;134:419–23

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 3
Total number of PDF views: 20 *
Loading metrics...

Abstract views

Total abstract views: 148 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 25th May 2017. This data will be updated every 24 hours.